Post-Activity Test and Activity Evaluation POST TEST Question Title * 1. According to the Centers for Disease Control and Prevention 2019 list of priority pathogens, which of the following bacteria is not considered an urgent threat? Carbapenem-resistant A. baumannii Carbapenem-resistant Enterobacteriaceae ESBL-producing Enterobacteriaceae Clostridioides difficile Question Title * 2. According to SENTRY Program data, which of the following statements is most accurate regarding bacterial resistance across the globe during the past 2 decades? Bacterial resistance rates have increased consistently regardless of pathogen and geographic region. The prevalence of ESBL-producing Enterobacteriaceae has generally increased in all geographic regions. Among resistant pathogens, the prevalence of MDR P. aeruginosa has increased the greatest. The prevalence of carbapenem-resistant Enterobacteriaceae has decreased across all geographic regions. Question Title * 3. Metallo-beta-lactamases can include all of the following except: IMP KPC NDM VIM Question Title * 4. Which of the following newer antimicrobials exhibits in vitro activity against metallo-beta-lactamases? Cefiderocol Meropenem-vaborbactam Ceftazidime-avibactam Eravacycline Question Title * 5. All of the following newer antimicrobials exhibit activity against carbapenem-resistant P. aeruginosa except: Ceftolozane-tazobactam Ceftazidime-avibactam Imipenem-relebactam Eravacycline Question Title * 6. Which of the following antimicrobials would be preferred for the treatment of urinary tract infection caused by ESBL-producing K. pneumoniae? Imipenem Imipenem-relebactam Plazomicin Cefepime Question Title * 7. A 57-year-old man who has been hospitalized and intubated for 5 days following emergency surgery develops ventilator-associated pneumonia. Rapid molecular diagnostics is performed on a BAL sample and identifies P. aeruginosa. The unit-based antibiogram reveals that over 60% of P. aeruginosa isolates exhibit multidrug resistance. Which of the following would be the most appropriate initial antimicrobial agent? Piperacillin-tazobactam Ceftolozane-tazobactam Imipenem Colistin plus gentamicin Question Title * 8. Which of the following is not an anticipated goal of rapid diagnostic testing? Increased use of broad-spectrum antimicrobial therapy Prevention of unnecessary drug toxicity Shorter time to optimal antimicrobial therapy Prevention of resistance emergence Next